Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy

• Published in: Neuroscience research Vol. 130; pp. 8 - 22
• Main Authors: Lamadrid-Romero, M., Solís, K.H., Cruz-Reséndiz, M.S., Pérez, J.E., Díaz, N.F., Flores-Herrera, H., García-López, G., Perichart, O., Reyes-Muñoz, E., Arenas-Huertero, F., Eguía-Aguilar, P., Molina-Hernández, A.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01-05-2018
• Subjects: Gestational diabetes mellitus; Neural development; Pregnancy; Serum miRNA; BMPR2; NT; CTNND1; Gestational diabetes mellitus; CNS; DGSR8; mRNA; ErbB; Dll1; ACTB; ACTG1; CRKL; Neural development; PPP2CA; GDM; Shh; Hes1; miRNA; TGF-β; YWHAG; Ascl1; NSC; FoxO; Np; CSNK2A2; Pregnancy; Serum miRNA; CCNG2; Rap1; MDM2; Olig1; ADA
• ISSN: 0168-0102; 1872-8111
• DOI: 10.1016/j.neures.2017.08.003

•Fetal-related neural miRNA levels vary during pregnancy.•Fetal-related neural miRNA levels are higher in the first trimester in gestational diabetes.•Neural-related miRNAs can be used as neural development biomarkers.
MicroRNAs are heterochronic molecules important during brain development, which could be altered by gestational diabetes mellitus (GDM). To explore these molecules in maternal serum, we performed an RT-qPCR analysis. Our results revealed the heterochronic character of some neural development-related microRNA in serum samples of pregnant women. In relation to the first trimester, higher levels of miR-183-5p, -200b-3p, and -125-5p in the second trimester, and higher levels of miR-137 in the third trimester, were found. Furthermore, an insult such as GDM led to higher levels of miR-183-5p, -200b-3p, -125-5p, and -1290 relative to the control in the first trimester, which might be related to changes in neurogenesis and cell proliferation. An in silico analysis suggested that increased microRNAs in the second trimester in the control contributed to cell proliferation and neuron differentiation and that the rise in miR-137 in the third trimester led to neuron maturation. In the diabetic, higher levels of the microRNAs in the first trimester suggested alterations in cell proliferation and neuron differentiation. In conclusion, we showed that fetal-related microRNAs can be detected in the serum of pregnant woman and exhibit temporary regulation during pregnancy and that microRNAs involved in cell proliferation and neuron differentiation are upregulated under GDM.